DiMartino Jorge 4
4 · Kronos Bio, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
DiMartino Jorge
Chief Medical Officer & VP
Transactions
- Award
Common Stock
2023-02-15+137,008→ 365,593 total - Award
Employee Stock Option (Right to Buy)
2023-02-15+205,513→ 205,513 totalExercise: $2.09Exp: 2033-02-14→ Common Stock (205,513 underlying)
Footnotes (2)
- [F1]Includes an aggregate of 9,107 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on the following dates: 1,991 shares on June 30, 2021, 640 shares on December 31, 2021 and 6,476 shares on December 30, 2022.
- [F2]1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.